2024 Q2 Form 10-Q Financial Statement

#000143774924013094 Filed on April 25, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $62.53M $57.30M $65.51M
YoY Change -7.74% 0.66% -12.55%
Cost Of Revenue $47.42M $42.95M $49.57M
YoY Change -7.25% -6.38% -19.1%
Gross Profit $15.11M $14.35M $15.94M
YoY Change -9.23% 29.88% 16.91%
Gross Profit Margin 24.17% 25.05% 24.33%
Selling, General & Admin $10.06M $10.70M $10.36M
YoY Change 3.01% 4.06% 18.11%
% of Gross Profit 66.59% 74.55% 64.99%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.378M $1.373M $1.451M
YoY Change -1.71% -1.65% -9.54%
% of Gross Profit 9.12% 9.57% 9.11%
Operating Expenses $10.06M $10.70M $10.98M
YoY Change -3.14% 4.06% 25.18%
Operating Profit $4.457M $3.060M $4.959M
YoY Change -28.78% 1953.69% 17.51%
Interest Expense $730.0K $735.0K -$1.069M
YoY Change -146.2% -46.55% -212.05%
% of Operating Profit 16.38% 24.02% -21.56%
Other Income/Expense, Net $3.000K $3.000K $1.000K
YoY Change -57.14% -83.33% -104.55%
Pretax Income $3.730M $2.328M $3.891M
YoY Change -20.38% -292.72% 19.94%
Income Tax $886.0K $553.0K $1.027M
% Of Pretax Income 23.75% 23.75% 26.39%
Net Earnings $2.844M $1.775M $2.864M
YoY Change -21.91% -286.45% -3.18%
Net Earnings / Revenue 4.55% 3.1% 4.37%
Basic Earnings Per Share $0.21 $0.13
Diluted Earnings Per Share $0.20 $0.13 $0.20
COMMON SHARES
Basic Shares Outstanding 13.86M 13.79M 13.74M
Diluted Shares Outstanding 14.05M 13.89M

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $362.0K $283.0K $16.00K
YoY Change -37.26% -95.33% -99.6%
Cash & Equivalents $362.0K $283.0K $16.00K
Short-Term Investments
Other Short-Term Assets $2.461M $2.949M $4.280M
YoY Change -37.3% -39.56% 3.31%
Inventory $86.57M $95.99M $92.46M
Prepaid Expenses $2.461M $2.949M $4.280M
Receivables $47.83M $52.27M $49.99M
Other Receivables $1.829M $0.00 $88.00K
Total Short-Term Assets $139.1M $151.5M $146.8M
YoY Change -19.47% -17.68% -29.89%
LONG-TERM ASSETS
Property, Plant & Equipment $23.44M $23.42M $23.79M
YoY Change -28.82% -5.1% -13.88%
Goodwill $42.33M $42.33M $42.33M
YoY Change 0.0% 0.0% 7.9%
Intangibles $27.46M $28.05M $28.64M
YoY Change -8.11% -8.04% -17.49%
Long-Term Investments
YoY Change
Other Assets $427.0K $459.0K $391.0K
YoY Change -86.97% 22.07% 49.81%
Total Long-Term Assets $104.0M $104.9M $106.2M
YoY Change -4.06% -4.29% -4.25%
TOTAL ASSETS
Total Short-Term Assets $139.1M $151.5M $146.8M
Total Long-Term Assets $104.0M $104.9M $106.2M
Total Assets $243.1M $256.3M $253.0M
YoY Change -13.53% -12.68% -21.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.80M $15.98M $9.797M
YoY Change -12.82% -7.26% -56.81%
Accrued Expenses $9.222M $9.484M $15.28M
YoY Change -15.39% -9.68% -19.82%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $7.143M $7.143M $7.143M
YoY Change 0.0% 0.0% 0.0%
Total Short-Term Liabilities $30.24M $34.10M $33.26M
YoY Change -7.59% -4.91% -33.07%
LONG-TERM LIABILITIES
Long-Term Debt $36.02M $46.38M $43.75M
YoY Change -53.1% -47.34% -56.06%
Other Long-Term Liabilities $297.0K $387.0K $387.0K
YoY Change -96.56% -4.91% -13.62%
Total Long-Term Liabilities $36.32M $46.77M $44.14M
YoY Change -57.49% -47.15% -55.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $30.24M $34.10M $33.26M
Total Long-Term Liabilities $36.32M $46.77M $44.14M
Total Liabilities $77.08M $91.63M $88.43M
YoY Change -37.16% -33.25% -45.76%
SHAREHOLDERS EQUITY
Retained Earnings $160.6M $159.8M $160.1M
YoY Change 10.99% 12.08% 11.41%
Common Stock $5.406M $4.909M $4.480M
YoY Change -60.65% -64.25% -67.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $166.0M $164.7M $164.6M
YoY Change
Total Liabilities & Shareholders Equity $243.1M $256.3M $253.0M
YoY Change -13.53% -12.68% -21.02%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $2.844M $1.775M $2.864M
YoY Change -21.91% -286.45% -3.18%
Depreciation, Depletion And Amortization $1.378M $1.373M $1.451M
YoY Change -1.71% -1.65% -9.54%
Cash From Operating Activities $13.29M $7.000K $20.62M
YoY Change 58.62% -99.84% -477.07%
INVESTING ACTIVITIES
Capital Expenditures $817.0K $357.0K $515.0K
YoY Change 124.45% -49.29% -301.17%
Acquisitions
YoY Change
Other Investing Activities $42.00K $50.00K $130.0K
YoY Change 225.0%
Cash From Investing Activities -$775.0K -$307.0K -$385.0K
YoY Change 112.91% -56.39% 78.24%
FINANCING ACTIVITIES
Cash Dividend Paid $2.063M
YoY Change 0.19%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $34.17M
YoY Change -2.06%
Cash From Financing Activities -12.44M $567.0K -21.14M
YoY Change -7.89% -133.06% -706.02%
NET CHANGE
Cash From Operating Activities 13.29M $7.000K 20.62M
Cash From Investing Activities -775.0K -$307.0K -385.0K
Cash From Financing Activities -12.44M $567.0K -21.14M
Net Change In Cash 79.00K $267.0K -911.0K
YoY Change -101.44% -87.27% -58.5%
FREE CASH FLOW
Cash From Operating Activities $13.29M $7.000K $20.62M
Capital Expenditures $817.0K $357.0K $515.0K
Free Cash Flow $12.48M -$350.0K $20.10M
YoY Change 55.63% -109.18% -485.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1055000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
46383000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3125000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7628000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
387000 usd
CY2024Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q1 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
159811000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
164720000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
256347000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16000 usd
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2023Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
441000 usd
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1041000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
991000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
33264000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
35866000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
43753000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
88082000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3125000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4516000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7897000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8398000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
387000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
407000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
91627000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
88426000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
137269000 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
2879000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
160099000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
153439000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
164579000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
253005000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56931000 usd
CY2023Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
34104000 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
156318000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-952000 usd
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000033488
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13736800
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13736800
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13729859
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13729859
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
4909000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
4480000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
293587000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
593000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3060000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
149000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
735000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
1375000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2328000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1208000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
553000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-256000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1775000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-952000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
158475000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-952000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
459000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2059000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
395000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
164579000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1775000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
429000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2063000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
164720000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1775000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1373000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1396000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
222000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
429000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
459000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-67000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-0 usd
CY2024Q1 esca Cash Flow Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
CashFlowAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-3859000 usd
CY2023Q1 esca Cash Flow Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
CashFlowAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
3218000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4516000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
357000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
704000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
50000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-307000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-704000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
36798000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
35231000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
34168000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
34887000 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
2063000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
2059000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
567000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1715000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
267000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2097000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3967000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
283000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6064000 usd
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Correction of Immaterial Errors</i></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">During the year ended December 31, 2023, management became aware of an error in reporting of common stock value within the consolidated balance sheet and statement of stockholders’ equity. Common stock previously was reported with a $1.00 stated value even though, per the Company’s Articles of Incorporation, the common stock has no par value. Additionally, components of equity that should have been reflected within common stock were improperly reported within retained earnings. We have reviewed historical activity reflected in common stock and retained earnings and have identified adjustments to be made to correct the immaterial reporting error. The consolidated balance sheet and consolidated statement of stockholders’ equity have been corrected and have been updated for prior years within this Form 10-Q.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">We assessed the materiality of this error on prior periods' financial statements in accordance with the Securities and Exchange Commission Staff Accounting Bulletin No. 99, <i>Materiality</i>, codified in Accounting Standards Codification (ASC) 250, <i>Presentation of Financial Statements</i>. We concluded that the error was not material to any prior annual or interim period and therefore, amendments of previously filed reports are not required. In accordance with ASC 250, we have corrected the reporting for all prior periods presented by revising the consolidated financial statements appearing herein. Periods not presented herein will be revised, as applicable, in future filings. The revisions had no impact on total assets, total liabilities, total shareholders' equity, net income or the cash flow statement.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The impact of this revision on our consolidated balance sheet and consolidated statement of stockholders’ equity as of March 31, 2023 was as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">As Previously</p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">Reported</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">Correction</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">As Corrected</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 52%;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">In Thousands</p> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Common Stock</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">13,730</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(10,851</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">2,879</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Retained Earnings</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">142,588</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">10,851</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">153,439</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Total Stockholders’ Equity</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">156,318</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">156,318</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
2879000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
153439000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
156318000 usd
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
3665000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4050000 usd
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
7311000 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
2595000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2308000 usd
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
3386000 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
89731000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
86104000 usd
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
111756000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
95991000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
92462000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
122453000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
429000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
459000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
991000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2816000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y3M18D
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
57304000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3060000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1775000 usd
CY2024Q1 us-gaap Assets
Assets
256347000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56931000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
149000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-952000 usd
CY2023Q1 us-gaap Assets
Assets
293587000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2100000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13786000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13648000
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
104000
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13890000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13648000
CY2024Q1 esca Revenue From Contract With Customer Excluding Assessed Tax Gross
RevenueFromContractWithCustomerExcludingAssessedTaxGross
64047000 usd
CY2023Q1 esca Revenue From Contract With Customer Excluding Assessed Tax Gross
RevenueFromContractWithCustomerExcludingAssessedTaxGross
62973000 usd
CY2024Q1 esca Sales Returns
SalesReturns
1836000 usd
CY2023Q1 esca Sales Returns
SalesReturns
1512000 usd
CY2024Q1 us-gaap Product Warranty Expense
ProductWarrantyExpense
445000 usd
CY2023Q1 us-gaap Product Warranty Expense
ProductWarrantyExpense
440000 usd
CY2024Q1 esca Sales Allowances
SalesAllowances
4462000 usd
CY2023Q1 esca Sales Allowances
SalesAllowances
4090000 usd
CY2024Q1 esca Sales Return And Allowances Goods
SalesReturnAndAllowancesGoods
6743000 usd
CY2023Q1 esca Sales Return And Allowances Goods
SalesReturnAndAllowancesGoods
6042000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
57304000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56931000 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
375000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
374000 usd
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
357000 usd
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
612000 usd
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
165000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
129000 usd
CY2024Q1 us-gaap Lease Cost
LeaseCost
897000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
1115000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
255000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
245000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y10M20D
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y9M14D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.052 pure
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0505 pure
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1111000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1445000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1401000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1314000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1074000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
4257000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10602000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1919000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
8683000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1055000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7628000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
8683000 usd

Files In Submission

Name View Source Status
0001437749-24-013094-index-headers.html Edgar Link pending
0001437749-24-013094-index.html Edgar Link pending
0001437749-24-013094.txt Edgar Link pending
0001437749-24-013094-xbrl.zip Edgar Link pending
esca-20240331.xsd Edgar Link pending
esca20240331_10q.htm Edgar Link pending
ex_657273.htm Edgar Link pending
ex_657274.htm Edgar Link pending
ex_657275.htm Edgar Link pending
ex_657276.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
esca-20240331_def.xml Edgar Link unprocessable
esca-20240331_lab.xml Edgar Link unprocessable
esca-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
esca20240331_10q_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
esca-20240331_cal.xml Edgar Link unprocessable